Category: Latest News
-
AgriFORCE shares surge after rebranding to AVAX One with $550M fundraising plan
AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) stock jumped 183% in premarket trading Monday after the company announced it will rebrand as AVAX One and launch a roughly $550 million fundraising initiative to invest in Avalanche’s native token. The company aims to become the first NASDAQ-listed entity with a dedicated strategy to maximize AVAX token holdings, creating…
-
Tempus AI shares rise after FDA clearance for RNA sequencing device
Tempus AI, Inc. (NASDAQ:TEM) stock climbed 5% on Monday after the company announced it received 510(k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR IVD device. The AI-driven precision medicine company will offer the newly cleared device as a life sciences tool to support drug development programs. The Tempus xR…
-
Atlas Lithium shares rise on strong rare earth results from subsidiary
Atlas Lithium Corp (NASDAQ:ATLX) stock climbed 2.9% in premarket trading Monday after its subsidiary reported encouraging results from rare earth projects in Brazil. Atlas Critical Minerals Corporation, a subsidiary of Atlas Lithium, unveiled promising outcomes from its diversified rare earth portfolio, which the company describes as Brazil’s most comprehensive rare earth project collection. The subsidiary…
-
Bitmine Immersion Technologies shares slide after $365M equity raise
Shares of Bitmine Immersion Technologies (NASDAQ:BMNR) fell 5.7% in premarket trading Monday following the company’s announcement of a $365.2 million equity offering. The cryptocurrency mining firm sold roughly 5.2 million shares at $70 each to an institutional investor through a registered direct offering, with Moelis & Co (NYSE:MC) acting as the sole placement agent. In…
-
MindWalk shares surge after dual-pathway GLP-1 therapeutic breakthrough
MindWalk Holdings Corp (NASDAQ:HYFT) stock soared 20.2% in premarket trading Monday following the company’s announcement of a major advancement in its AI-designed GLP-1 therapeutics program. The Bio-Native AI firm revealed that its LensAI platform has identified a previously unknown link between GLP-1 biology and a second pathway connected to healthy aging and systemic resilience. This…
-
Laser Photonics shares jump after securing semiconductor giant order
Laser Photonics Corp (NASDAQ:LASE) stock climbed 17.6% in Monday premarket trading following the announcement of a multi-system order from a top-five global semiconductor capital equipment company. The industrial laser systems maker said the order was obtained through its Beamer Laser Marking Systems subsidiary, acquired as part of its strategic growth plan. The deal represents a…
-
Iris Energy shares jump after doubling AI Cloud GPU capacity
IREN Ltd (NASDAQ:IREN) stock rose 10.3% in premarket trading Monday following the company’s announcement that it has doubled its AI Cloud GPU capacity to 23,000 units and set an ambitious revenue target. The firm acquired an additional 12,400 GPUs—comprising 7,100 NVIDIA B300s, 4,200 NVIDIA B200s, and 1,100 AMD MI350Xs—for roughly $674 million. With this expansion,…
-
Attend the 17th Annual Capital Link New York Maritime Forum And Meet Global Leaders
Capital Link welcomes institutional investors, analysts, shipping executives, and all professionals in the maritime sector to the 17th Annual New York Maritime Forum (NYMF) on Tuesday, October 14, 2025, at the Metropolitan Club in New York City. Hosted in partnership with DNB and in collaboration with Nasdaq and NYSE, the Forum offers a premier platform…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Stocks Poised to Pull Back After Record Rally
Futures tied to the major U.S. indexes pointed lower on Monday, signaling a potential retreat on Wall Street after two straight sessions of gains that lifted benchmarks to all-time highs. Analysts said profit-taking was likely playing a role, with traders choosing to cash in after Friday’s strong close that followed the Federal Reserve’s decision to…
-
MBX Biosciences shares jump on positive Phase 2 results for hypoparathyroidism drug
MBX Biosciences (NASDAQ:MBX) stock surged 16% after announcing that its investigational therapy canvuparatide, a once-weekly injection, successfully met the primary endpoint in a Phase 2 trial for chronic hypoparathyroidism. The company said 63% of patients on canvuparatide achieved the composite endpoint at 12 weeks, compared with 31% in the placebo arm, reaching statistical significance (p=0.042).…